Stay updated on ADP-A2M4CD8 in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the ADP-A2M4CD8 in Ovarian Cancer Clinical Trial page.

Latest updates to the ADP-A2M4CD8 in Ovarian Cancer Clinical Trial page
- Check6 days agoChange DetectedA new revision entry v3.5.4 was added and the previous v3.5.3 entry removed from the study record history. This updates the page’s version history to reflect the latest site revision.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe footer/footer build label for the site updates to a new revision version (v3.5.3), with no visible change to the ClinicalTrials.gov record history content.SummaryDifference0.1%

- Check34 days agoChange DetectedNew history entry Revision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision: v3.5.0 was added and revision: v3.4.3 was deleted from the Record History.SummaryDifference0.1%

- Check70 days agoChange DetectedAdded revision v3.4.3 and removed revision v3.4.2 from the history.SummaryDifference0.1%

- Check84 days agoChange DetectedSponsor/collaborator details changed from Adaptimmune to USWM CT, LLC and USWM, LLC (dba US WorldMeds). New sections Oversight, Sponsor/Collaborators, Study Status, and Study Identification were added, with updates dated February 2026.SummaryDifference1%

Stay in the know with updates to ADP-A2M4CD8 in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADP-A2M4CD8 in Ovarian Cancer Clinical Trial page.